Celgene (CELG) Announces Settlement of U.S. REVLIMID Patent Litigation with Alvogen
March 29, 2019 12:00 PM
Celgene Corporation (NASDAQ: CELG) and Lotus Pharmaceutical Co., Ltd. and Alvogen Pine Brook, LLC (collectively, Alvogen) today announced the settlement ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
